Cargando…

Does the Use of the “Proseek(®) Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions?

Endometriotic lesions are able to infiltrate surrounding tissue. This is made possible partly by an altered local and systemic immune response that helps achieve neoangiogenesis, cell proliferation and immune escape. Deep-infiltrating endometriosis (DIE) differs from other subtypes through the invas...

Descripción completa

Detalles Bibliográficos
Autores principales: Perricos, Alexandra, Husslein, Heinrich, Kuessel, Lorenz, Gstoettner, Manuela, Weinhaeusel, Andreas, Eiwegger, Thomas, Beikircher, Gabriel, Wenzl, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003683/
https://www.ncbi.nlm.nih.gov/pubmed/36902452
http://dx.doi.org/10.3390/ijms24055022
_version_ 1784904661396881408
author Perricos, Alexandra
Husslein, Heinrich
Kuessel, Lorenz
Gstoettner, Manuela
Weinhaeusel, Andreas
Eiwegger, Thomas
Beikircher, Gabriel
Wenzl, René
author_facet Perricos, Alexandra
Husslein, Heinrich
Kuessel, Lorenz
Gstoettner, Manuela
Weinhaeusel, Andreas
Eiwegger, Thomas
Beikircher, Gabriel
Wenzl, René
author_sort Perricos, Alexandra
collection PubMed
description Endometriotic lesions are able to infiltrate surrounding tissue. This is made possible partly by an altered local and systemic immune response that helps achieve neoangiogenesis, cell proliferation and immune escape. Deep-infiltrating endometriosis (DIE) differs from other subtypes through the invasion of its lesions over 5 mm into affected tissue. Despite the invasive nature of these lesions and the wider range of symptoms they can trigger, DIE is described as a stable disease. This elicits the need for a better understanding of the underlying pathogenesis. We used the “Proseek(®) Multiplex Inflammation I Panel” in order to simultaneously detect 92 inflammatory proteins in plasma and peritoneal fluid (PF) of controls and patients with endometriosis, as well as in particular patients with DIE, in order to gain a better insight into the systemically and locally involved immune response. Extracellular newly identified receptor for advanced gycation end-products binding protein (EN-RAGE), C-C motif Chemokine ligand 23 (CCL23), Eukaryotic translation initiation factor 4—binding protein 1 (4E-BP1) and human glial cell-line derived neurotrophic factor (hGDNF) were significantly increased in plasma of endometriosis patients compared to controls, whereas Hepatocyte Growth factor (HGF) and TNF-related apoptosis inducing ligand (TRAIL) were decreased. In PF of endometriosis patients, we found Interleukin 18 (IL-18) to be decreased, yet Interleukin 8 (IL-8) and Interleukin 6 (IL-6) to be increased. TNF-related activation-induced cytokine (TRANCE) and C-C motif Chemokine ligand 11 (CCL11) were significantly decreased in plasma, whereas C-C motif Chemokine ligand 23 (CCL23), Stem Cell Factor (SCF) and C-X-C motif chemokine 5 (CXCL5) were significantly increased in PF of patients with DIE compared to endometriosis patients without DIE. Although DIE lesions are characterized by increased angiogenetic and pro-inflammatory properties, our current study seems to support the theory that the systemic immune system does not play a major role in the pathogenesis of these lesions.
format Online
Article
Text
id pubmed-10003683
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100036832023-03-11 Does the Use of the “Proseek(®) Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions? Perricos, Alexandra Husslein, Heinrich Kuessel, Lorenz Gstoettner, Manuela Weinhaeusel, Andreas Eiwegger, Thomas Beikircher, Gabriel Wenzl, René Int J Mol Sci Article Endometriotic lesions are able to infiltrate surrounding tissue. This is made possible partly by an altered local and systemic immune response that helps achieve neoangiogenesis, cell proliferation and immune escape. Deep-infiltrating endometriosis (DIE) differs from other subtypes through the invasion of its lesions over 5 mm into affected tissue. Despite the invasive nature of these lesions and the wider range of symptoms they can trigger, DIE is described as a stable disease. This elicits the need for a better understanding of the underlying pathogenesis. We used the “Proseek(®) Multiplex Inflammation I Panel” in order to simultaneously detect 92 inflammatory proteins in plasma and peritoneal fluid (PF) of controls and patients with endometriosis, as well as in particular patients with DIE, in order to gain a better insight into the systemically and locally involved immune response. Extracellular newly identified receptor for advanced gycation end-products binding protein (EN-RAGE), C-C motif Chemokine ligand 23 (CCL23), Eukaryotic translation initiation factor 4—binding protein 1 (4E-BP1) and human glial cell-line derived neurotrophic factor (hGDNF) were significantly increased in plasma of endometriosis patients compared to controls, whereas Hepatocyte Growth factor (HGF) and TNF-related apoptosis inducing ligand (TRAIL) were decreased. In PF of endometriosis patients, we found Interleukin 18 (IL-18) to be decreased, yet Interleukin 8 (IL-8) and Interleukin 6 (IL-6) to be increased. TNF-related activation-induced cytokine (TRANCE) and C-C motif Chemokine ligand 11 (CCL11) were significantly decreased in plasma, whereas C-C motif Chemokine ligand 23 (CCL23), Stem Cell Factor (SCF) and C-X-C motif chemokine 5 (CXCL5) were significantly increased in PF of patients with DIE compared to endometriosis patients without DIE. Although DIE lesions are characterized by increased angiogenetic and pro-inflammatory properties, our current study seems to support the theory that the systemic immune system does not play a major role in the pathogenesis of these lesions. MDPI 2023-03-06 /pmc/articles/PMC10003683/ /pubmed/36902452 http://dx.doi.org/10.3390/ijms24055022 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Perricos, Alexandra
Husslein, Heinrich
Kuessel, Lorenz
Gstoettner, Manuela
Weinhaeusel, Andreas
Eiwegger, Thomas
Beikircher, Gabriel
Wenzl, René
Does the Use of the “Proseek(®) Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions?
title Does the Use of the “Proseek(®) Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions?
title_full Does the Use of the “Proseek(®) Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions?
title_fullStr Does the Use of the “Proseek(®) Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions?
title_full_unstemmed Does the Use of the “Proseek(®) Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions?
title_short Does the Use of the “Proseek(®) Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions?
title_sort does the use of the “proseek(®) multiplex inflammation i panel” demonstrate a difference in local and systemic immune responses in endometriosis patients with or without deep-infiltrating lesions?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003683/
https://www.ncbi.nlm.nih.gov/pubmed/36902452
http://dx.doi.org/10.3390/ijms24055022
work_keys_str_mv AT perricosalexandra doestheuseoftheproseekmultiplexinflammationipaneldemonstrateadifferenceinlocalandsystemicimmuneresponsesinendometriosispatientswithorwithoutdeepinfiltratinglesions
AT hussleinheinrich doestheuseoftheproseekmultiplexinflammationipaneldemonstrateadifferenceinlocalandsystemicimmuneresponsesinendometriosispatientswithorwithoutdeepinfiltratinglesions
AT kuessellorenz doestheuseoftheproseekmultiplexinflammationipaneldemonstrateadifferenceinlocalandsystemicimmuneresponsesinendometriosispatientswithorwithoutdeepinfiltratinglesions
AT gstoettnermanuela doestheuseoftheproseekmultiplexinflammationipaneldemonstrateadifferenceinlocalandsystemicimmuneresponsesinendometriosispatientswithorwithoutdeepinfiltratinglesions
AT weinhaeuselandreas doestheuseoftheproseekmultiplexinflammationipaneldemonstrateadifferenceinlocalandsystemicimmuneresponsesinendometriosispatientswithorwithoutdeepinfiltratinglesions
AT eiweggerthomas doestheuseoftheproseekmultiplexinflammationipaneldemonstrateadifferenceinlocalandsystemicimmuneresponsesinendometriosispatientswithorwithoutdeepinfiltratinglesions
AT beikirchergabriel doestheuseoftheproseekmultiplexinflammationipaneldemonstrateadifferenceinlocalandsystemicimmuneresponsesinendometriosispatientswithorwithoutdeepinfiltratinglesions
AT wenzlrene doestheuseoftheproseekmultiplexinflammationipaneldemonstrateadifferenceinlocalandsystemicimmuneresponsesinendometriosispatientswithorwithoutdeepinfiltratinglesions